H]DHEA-FAE entered cells via LDL receptor or LDL receptorrelated receptor-mediated uptake, followed by intracellular hydrolysis and further metabolism into 5␣-adione and 4-adione that were excreted from cells. Although LAL contributed to the deesterification of DHEA-FAE, it was not solely responsible for the hydrolysis. ribonucleic acid interference; chromatography; dehydroepiandrosterone STEROID FATTY ACYL ESTERS (FAE) such as 17␤-estradiol-FAE (E 2 -FAE) and dehydroepiandrosterone-FAE (DHEA-FAE) belong to a unique family of naturally occurring hydrophobic hormone derivatives (15, 16). These steroids are esterified in a reaction catalyzed by plasma lecithin-cholesterol acyltransferase associated with high-density lipoprotein (HDL) particles and transported to other lipoprotein particles (14, 18, 30, 35, 42) . The physiological role of steroid-FAE remains unclear. E 2 -FAE have been considered as the storage form of active estrogen in lipoproteins and adipose tissues that may be released as an active unconjugated hormone (3). It has also been suggested that E 2 -FAE may act as an antioxidant, protecting lipoproteins against oxidation (17, 41). Our previous studies (4) in a cell culture model demonstrated that lipoprotein-associated E 2 -FAE can be transferred into target cells and hydrolyzed to free E 2 .
E 2 -FAE have been considered as the storage form of active estrogen in lipoproteins and adipose tissues that may be released as an active unconjugated hormone (3) . It has also been suggested that E 2 -FAE may act as an antioxidant, protecting lipoproteins against oxidation (17, 41) . Our previous studies (4) in a cell culture model demonstrated that lipoprotein-associated E 2 -FAE can be transferred into target cells and hydrolyzed to free E 2 .
Compared with E 2 -FAE that is present in picomolar concentration in the circulation, nanomolar concentrations of circulating DHEA-FAE have been reported (7, 26) . Moreover, its hydrolysis product, DHEA, is one of the relatively abundant adrenal steroids secreted in humans and the precursor of estrogens and androgens (24) . In blood, Ͼ90% of DHEA-FAE is associated with lipoproteins (38, 39) . We are interested in the intracellular hydrolysis and metabolic fate of lipoproteinbound DHEA-FAE in target tissues.
In postmenopausal women, only trace amounts of E 2 are present in serum, the overwhelming majority of estradiol residing in adipose tissue, mostly in the form of FAE (3) . This finding opens up the possibility that adipose tissue could constitute a reservoir of many other steroid-FAEs from which active steroid hormones could, in principle, be liberated by hydrolysis of the FAE bond. Therefore, we aimed at exploring possible hydrolytic mechanisms involved in generating free DHEA and identifying potential bioactive metabolites of DHEA generated in cells. Lysosomal acid lipase (LAL) is the enzyme responsible for the intracellular hydrolysis of LDLassociated cholesteryl esters (cholesteryl-FAE) that are taken up by LDL-receptor-mediated endocytosis (12) . Because of the similar ring structure of DHEA and cholesterol, we investigated the possibility that DHEA-FAE is also hydrolyzed by LAL. We chose HeLa cells as a model to study the hydrolysis and metabolism of LDL-associated DHEA-FAE because these cells, derived from the reproductive tract, have previously been useful in the study cholesterol metabolism (19, 22, 37) . Moreover, HeLa cells express LAL mRNA (1) and RNA silencing works very reproducibly in these cells. Thus we investigated whether LDL-associated DHEA-FAE is taken up by LDL receptors, and then hydrolyzed by LAL, and whether DHEA is further converted to other metabolites. H]DHEA, 4-(dimethylamino) pyridine, and 1-butyl-3-methylimidazolium bromide was placed in a microwave vial and dried in an oil pump for a couple of hours. Then, dry pyridine and linoleyl chloride (Sigma Chemical, St. Louis, MO) were added. The mixture was microwave irradiated and then quenched by pouring it into ice-cold water, and the product was extracted with ethyl acetate and washed by NAHCO 3 and brine. The organic phase was dried with sodium sulfate and evaporated. The product was purified in a Sephadex LH-20 column. Unlabeled standards for TLC (see Table 1 for abbreviations used): DHEA was from Sigma Chemical. [ 3 H]androstenedione (4-adione) was from MANN research laboratory (New York, NY). 5␣-Androstanedione (5␣-adione), 5␣-androstan-3␣-ol-17-one, 5␣-DHT, 3␤,5␣-adiol, 3␣,5␣-adiol, and 3␤,5␣-adiol-17␣ were from Steraloids. Testosterone and 5␣-androstan-3␤-ol-17-one were from Ikapharm (Ramat-Gan, Israel). DHEA-oleate was prepared using the same methodology for [ 3 H]DHEA-linoleate synthesis. All of the unlabeled steroids are listed in Fig. 1 . Cell culture media were from BioWhittaker, short-interfering RNA oligonucleotides (siRNAs) were from Ambion and Sigma Chemical, anti-acid lipase (LAL) antibody from Abcam (ab36597), anti-actin antibody from Sigma, and horseradish peroxidase-conjugated secondary antibodies from Bio-Rad.
MATERIALS AND METHODS

Materials
Preparation of very low density lipoprotein-free plasma. Blood was drawn from healthy, normolipidemic adult female volunteers into vacuum tubes containing EDTA as anticoagulant. Plasma was isolated by centrifugation at 2,500 g for 15 min at ϩ4°C. Plasma lipoproteins were isolated by sequential ultracentrifugation (13) . Before the incubation of plasma with [ 3 H]DHEA, the very low density lipoprotein (VLDL) fraction was isolated at the density of d Ͻ 1.006 g/ml in a Beckman Optima LE-80K ultracentrifuge using a Ti 50.4 rotor (270,000 g, 3.5 h, 10°C), and the VLDL-free plasma was stored at Ϫ20°C until use. (32) , and the radioactivity was determined using liquid scintillation counting (Rackbeta liquid scintillation counter). The peak fractions containing radioactivity and protein were pooled and used for further analysis and cell culture experiments.
Cell culture. HeLa cells were cultured as described by Blom et al. (8) and primary human fibroblasts as described by Hölttä-Vuori (20) . Before radiolabelings, the cells were grown for 4 days in lipoproteindeficient-serum (prepared as in Ref. 11) to increase the expression of LDL receptors. Steroid FAE hydrolysis was analyzed from 70 -90% confluent cell cultures, because we noted that the rate of hydrolysis was slowed down in fully confluent cultures.
Incubations of cells with radiolabeled LDL. Cells on 6-cm dishes were incubated with [ 3 H]cholesteryl-FAE-LDL or [
3 H]DHEA-FAE-LDL (50 g/ml protein) in 1 ml of serum-free DMEM for 6 h (HeLa cells) or 8 h (primary fibroblasts). Unless otherwise noted, the cells were washed three times with PBS and chased in 2 ml serum-free medium for 14 -24 h (HeLa cells) or 24 -48 h (primary fibroblasts), after which the cells and media were collected for analysis. The acyl-CoA:cholesterol acyltransferase inhibitor PKF 058 -035 (2 g/ ml) was present during labeling and chase to inhibit cellular reesterification of the hydrolyzed [
3 H]cholesterol and [ 3 H]DHEA. To compete the labeling with excess unlabeled LDL, the cells in 12-well plate wells were incubated in the presence of unlabeled LDL (2.5 mg/ml) for 30 min in 0.5 ml serum-free medium followed by the addition of [ 3 H]DHEA-FAE-LDL (50 g/ml) and incubation for further 6 -8 h. After being washed three times with PBS, the cells were scraped in 1% Nonidet P-40 in PBS. Cellular radioactivity was measured using WALLAC 1409 liquid scintillation counter, and the protein amounts were determined by Wallac 1420 Victor 2 multilabel counter.
Depletion of LAL using siRNAs and analysis of steroid-FAE hydrolysis. To deplete LAL from HeLa cells, LAL siRNAs (oligonucleotide duplexes: sense, 5Ј-GGACUUAUUUGGAGACAAAtt; and antisense, 5Ј-UUUGUCUCCAAAUAAGUCCtt) were transfected into cells using Lipofectamine (Invitrogen) according to the manufacturer's instructions. Control cells were similarly transfected with irrelevant siRNAs (GL2; Ref. 9). At 4 h posttransfection, the cells were washed with PBS for three times and changed to 5% lipoproteindeficient-serum DMEM. After 3 days, the cells were either harvested for Western blotting or incubated with [
3 H]cholesteryl-FAE-LDL or [ 3 H]DHEA-FAE-LDL for 6 h followed by 14 or 24 h of chase. The fraction of [ 3 H]steroid-FAE left at 14 h of chase was quantified relative to 24 h of chase, i.e., complete hydrolysis where no difference between control and LAL siRNA treated cells was observed. This is because residual enzyme activity in LAL-depleted cells abolishes the difference at prolonged incubations.
Western blotting. Cells were scraped in 1% NP40 in PBS in the presence of protease inhibitors (chymostatin, leupeptin, antipain, and pepstatin at 25 g/ml each). Proteins (20 g of cell lysate) were separated by 10% SDS-PAGE and transferred onto nitrocellulose membrane (Amersham). Unspecific binding was blocked with 5% ]DHEA-FAE-LDL, lipids were extracted four times with diethyl ether (with 2-2.5ϫ sample volume). The water phase was frozen in dry ice/ ethanol, followed by removal of the organic layer and its evaporation to dryness under N 2. To extract radiolabeled steroids from the cells, the cell monolayer was treated with isopropanol for 1 h at room temperature, after which the solvent was collected and evaporated to dryness under N 2. The dry residue was dissolved in 1 ml methanol and stored at 4°C until further analysis.
Hydrophobic chromatography. ]-4-adione were applied as standards. Two-dimensional TLC on silica gel G-60 was used with the following nonlabeled standards: DHEA-oleate, free DHEA, 5␣-adione, and 4-adione. Solvent system 1 was used for the first run and solvent system 3 (dichloromethane-acetone, 92.5:7.5, vol/vol) for the second run. The TLC plates (16 cm) were air dried after chromatography. The locations of the nonlabeled standards were visualized under ultraviolet light after rhodamine staining. The locations of the samples containing [ 3 H] label were detected and analyzed by using Cyclone Storage Phosphor System with OptiQuant software (Packard Instrument). The TLC plates were exposed to the [ 3 H]-sensitive screen for 3 days.
Samples from experiments exploring the role of LAL on DHEA-FAE hydrolysis were subjected to TLC on silica gel G-60 using solvent system 1. The nonradioactive standards DHEA-oleate and DHEA were applied on the same plate. After the locations of the standards were determined by ultraviolet light with rhodamine staining, the locations of the samples containing [ 3 H] label were determined by scraping 1 ϫ 1-or 1 ϫ 1.5-cm strips, followed by transfer of the material to vials in 500 l methanol for liquid scintillation counting, using strips of clean plate as blanks.
Statistical analysis.
Data represent means of multiple experiments. Error bars represent SD. The t-test was performed as for two-sample assuming unequal variances. All statistical analyses were performed with Microsoft Excel 2002 (Microsoft, Redmond, WA).
RESULTS
Cellular uptake and hydrolysis of DHEA-FAE introduced in LDL.
To analyze the LDL-receptor-dependent uptake and metabolism of [ 3 H]DHEA-FAE, we incorporated [ 3 H]DHEA-FAE into LDL and incubated HeLa cells with the labeled LDL. As expected, the intracellular radioactivities increased with increasing incubation time (data not shown), and by 6 h of incubation, the cell associated radioactivity was ϳ10 000 dpm/mg cellular protein ( Fig. 2A) . This cellular uptake was mediated by LDL receptor or LDL receptor-related receptors as shown by effective displacement of the label by 50-fold excess unlabeled LDL ( Fig. 2A) (Fig. 2B) . In contrast, the [ 3 H] label obtained from the medium fraction contained little activity in the ester fraction, the majority eluting in the fractions corresponding to unesterified DHEA and other metabolites. This suggests intracellular hydrolysis with formation of free DHEA and some other metabolites that were secreted into the medium.
Cellular metabolites of DHEA-FAE. We used TLC to identify radiolabeled metabolites. DHEA-oleate migrated faster than free DHEA and other unesterified metabolites. As shown in Fig. 3 , intracellular radioactivity comigrated with DHEAlinoleate standard while the activity from the medium fraction partly corresponded to unesterified DHEA and partly migrated faster than DHEA.
Two-dimensional TLC demonstrated that all the [ 3 H] label in the cellular fraction comigrated with the nonlabeled DHEAoleate standard (Fig. 4) . Using the metabolites of DHEA, including 4-adione, 5␣-adione, 5␣-androstan-3␣-ol-17-one, 3␤,5␣-adiol-17␣, 5␣-DHT, 3␣,5␣-adiol, 3␤,5␣-adiol, testos- DHEA-FAE, dehydroepiandrosterone-fatty acyl ester; 4-adione, androstenedione; 5␣-adione, 5␣-androstanedione; A, 5␣-androstan-3␣-ol-17-one; 3␤,5␣-adiol, 5␣-androstane-3␤,17␤-diol; T, testosterone; 5␣-DHT, 5␣-androstan-17␤-ol-3-one; 3␣,5␣-adiol, 5␣-androstane-3␣,17␤-diol; 3␤,5␣-adiol-17␣, 5␣-androstane-3␤,17␣-diol; epiA, 5␤-androstan-3␣-ol-17-one; E1, estrone; E2, 17␤-estradiol. 1, 3␤ hydroxysteroid dehydrogenase (HSD)-1; 2, 5␣ reductase-1 and 5␣ reductase-2; 3, 3␣ HSD-1 and 3␣ HSD-1; 4, 3␣ HSD-4; 5, 3(␣3␤)-hydroxysteroid epimerase (HES); 6, aromatase; 7, 3␤ HSD-1; 8, 17␤ HSD-7 [3(␣3␤)-HES]; 9, 17␤ HSD-3,5,13; 10, 17␤ HSD-2; 11, 17␤ HSD-1,7,12; and 12, 17␤ HSD-2 and 17␤ HSD-4. The figure is modified from Ref. 24. terone, and 5␣-androstan-3␤-ol-17-one as reference steroids, we demonstrated by two-dimensional TLC that in addition only three metabolites, free DHEA, 5␣-adione and 4-adione, could be detected in the medium fraction. Among these four identified substances that comigrated with cold standards, most of the radiolabel corresponded to 5␣-adione, some to free DHEA, 4-adione, and DHEA-FAE (Fig. 4) . The existence of small amounts of other unidentified metabolites could not be excluded.
Involvement of lysosomal acid lipase in DHEA-FAE hydrolysis. To study whether LAL is involved in the intracellular hydrolysis of [ 3 H]DHEA-FAE, we depleted LAL from HeLa cells using siRNAs. A 3-day treatment with siRNAs resulted in the loss of the majority of LAL protein from the cells as assessed by Western blotting (Fig. 5A) . LAL is considered to be responsible for the hydrolysis of LDL-cholesteryl ester. Accordingly, we found that the hydrolysis of [ 3 H]cholesteryl-FAE-LDL was significantly inhibited in LAL-depleted cells compared with cells incubated with control siRNAs (Fig. 5B) (2) and no immunoreactive LAL was detectable by immunoblotting in the patient fibroblasts (Fig. 6A) . Also, the absence of [ H]DHEA-FAE hydrolysis is not dependent on a functional LAL but that a partial role for LAL in the hydrolysis cannot be excluded. 3 H]DHEA-FAE-LDL (50 g protein/ml) for 6 h, the label was removed, and the cells were chased for 2 days. Cells and media were collected, and lipids were extracted and resolved using a Sephadex LH-20 column. From cellular material, most of the [ 3 H] label eluted in fractions 5-7 comigrating with the DHEA-FAE standard. From the medium, only a small part of the [ 3 H] label was present in the ester fractions, and the peak of [ 3 H] radioactivity was found in fractions eluting after DHEA-FAE but before free DHEA, suggesting that it was converted to metabolite(s).
DISCUSSION
We investigated the role of LAL on the hydrolysis of LDL-associated In circulation, the amount of esterified DHEA is ϳ40 -50% of that of biologically active free DHEA in middle aged men and its proportion increases with aging (7). The majority of circulating DHEA-FAE is incorporated in lipoproteins, with 46% associated with LDL and 37% with HDL (28, 38) . In the cellular fraction, essentially all the radioactivity comigrated with DHEA-oleate. In the medium fraction, the majority comigrated with the 5␣-adione standard, whereas smaller amounts comigrated with free DHEA and 4-adione. S, start 1, first running; , second running. Growing evidence suggests that plasma lipoproteins may play a physiological role in transferring DHEA-FAE and other steroid-FAE to target tissues via lipoprotein-mediated pathways. In both porcine granulosa cells and guinea pig adrenal cells, HDL-or LDL-associated pregnenolone-FAE could be converted into free progesterone, a metabolite of pregnenolone (36, 40) . Roy and Belanger (39) demonstrated that LDLincorporated lipoidal (esterified) DHEA could be delivered into ZR-75-1 breast cancer cells by a lipoprotein-mediated pathway, after which nonesterified DHEA and 3␤,5␣-adiol were generated in the cells. This provided the first evidence that LDL-associated hormonally inactive DHEA-FAE can act as a source of biologically active hormones. The LDL receptor belongs to a family of structurally and functionally related cell surface receptors, most of which can bind and internalize LDL (10, 21, 34) . Therefore, although the LDL receptor is highly expressed in lipoprotein-starved human fibroblasts and also abundant in HeLa cells, we cannot exclude the possibility that additional members of the LDL receptor family may take part in the internalization. In addition, in LDL competition experiments, there was a small residual amount of [ 3 H] label in the presence of excess unlabeled LDL. This could reflect LDL independent uptake, which would nevertheless be quantitatively minor (representing ϳ10% of the total uptake).
DHEA is the precursor for sex steroids in steroidogenic tissues ( Fig. 1 ; modified from Ref. 24 ) and also in peripheral tissues, depending on the expression of specific androgen-and estrogen-synthesizing enzymes (25) . In our HeLa cell model, the presence of at least three unesterified steroids (free DHEA, 4-adione, and 5␣-adione) in the medium fraction demonstrated that LDL-associated DHEA-FAE could be converted into free DHEA and further metabolized to biologically active metabolites after intracellular delivery. The finding that only DHEA-FAE was identified in the cellular fraction suggests that DHEA-FAE was hydrolyzed intracellularly and that the unesterified steroids were effectively secreted out of the cells into the surrounding medium. The production of 4-adione and 5␣-adione from DHEA suggested that steroidogenic enzyme activities exist in HeLa cells. However, DHEA-FAE associated with lipoproteins had a surprisingly short half-life in plasma (ϳ40 min) when injected into guinea pigs (6) . This is in contrast to E 2 -FAE that exhibited a much longer half-time (6 h) in the rat (27) . Further studies on the metabolic fate of lipoprotein-associated DHEA-FAE are needed to understand the physiological role of these differences.
Enzymatic hydrolysis is the key to the biological activity of steroid-FAE because they are hormonally inactive and are not able to bind to steroid receptors. Most of our knowledge about the hydrolytic enzymes of steroid-FAE comes from studies on E 2 -FAE. For example, an esterase that hydrolyzed E 2 -FAE was detected in a breast cancer cell line (23). Banerjee et al. (5) have isolated an esterase, with a molecular mass of 90 kDa, from human breast cyst fluid that deesterifies E 2 -FAE. They reported that the esterase was present at varying concentrations in 367 women, and they suggested that elevated esterase activity predicted breast cancer (31) . Moreover, in one study (29) , the esterase of bovine placental cotyledons that hydrolyzed E 2 -FAE (and DHEA-FAE) was proposedly similar, if not identical, to hormone-sensitive lipase. The possibility that other esterases exist could not, however, be excluded (29) . In our study, the hydrolysis of DHEA-FAE was reduced in LAL depleted HeLa cells as well as in LAL deficient fibroblasts compared with control cells. This demonstrated that LAL is one of the enzymes involved in the hydrolysis of DHEA-FAE. However, the magnitude of reduction of DHEA-FAE hydrolysis was less than that of cholesteryl oleate hydrolysis, indicating that one or more other esterases may contribute. Such hydrolytic enzymes may provide active DHEA in various tissues, which can be converted to other biologically active metabolites. Reportedly, E 2 -FAE induce mammary tumorigenesis in female rats proposedly due to high local esterase activity (33) . Therefore, further studies are needed to explore the esterases responsible for the hydrolysis of DHEA-FAE and their regulation in tissues, such as the adipose tissue of the human breast.
In conclusion, the inactive prohormone DHEA-FAE may be transported bound to LDL in circulation and enter peripheral cells via LDL receptor or LDL receptor-related receptors. After intracellular hydrolysis, biologically active free DHEA is metabolized into other steroids. LAL contributes to the hydrolysis of DHEA-FAE, which is a process involving more than one esterase. Fig. 5 . The fraction of steroid esters present immediately after labeling, after 1 day of chase, or after 2 days of chase is shown (n ϭ 2 for control and n ϭ 2-5 for Wolman cells; **P Ͻ 0.001).
